ChemRxiv
These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
1/1

What Can Digitization Do For Formulated Product Innovation and Development

preprint
revised on 01.02.2020 and posted on 03.02.2020 by James McDonagh, William Swope, Richard L. Anderson, Michael Johnston, David J. Bray
Digitization offers significant opportunities for the formulated product industry to transform the way it works and develop new methods of business. R&D is one area of operation that is challenging to take advantage of these technologies due to its high level of domain specialisation and creativity but the benefits could be significant. Recent developments of base level technologies such as artificial intelligence (AI)/machine learning (ML), robotics and high performance computing (HPC), to name a few, present disruptive and transformative technologies which could offer new insights, discovery methods and enhanced chemical control when combined in a digital ecosystem of connectivity, distributive services and decentralisation. At the fundamental level, research in these technologies has shown that new physical and chemical insights can be gained, which in turn can augment experimental R&D approaches through physics-based chemical simulation, data driven models and hybrid approaches. In all of these cases, high quality data is required to build and validate models in addition to the skills and expertise to exploit such methods. In this article we give an overview of some of the digital technology demonstrators we have developed for formulated product R&D. We discuss the challenges in building and deploying these demonstrators.

Funding

This work was supported by the STFC Hartree Centre’s Innovation: Return on Research programme, funded by the Department for Business, Energy & Industrial Strategy.

History

Email Address of Submitting Author

james.mcdonagh@uk.ibm.com

Institution

IBM Research

Country

UK

ORCID For Submitting Author

0000-0002-2323-6898

Declaration of Conflict of Interest

No conflicts

Version Notes

Minor typo updates from the original version

Exports